Aurobindo Pharma Announces 39th AGM on Aug 27, 2026, via VC/OAVM
Aurobindo Pharma Limited will hold its 39th AGM on August 27, 2026, via VC/OAVM. The Register of Members and Share Transfer Books will be closed from August 26 to August 27, 2026, for the AGM.
The announcement is a standard procedural update regarding the AGM and book closure dates. It does not contain any new financial information, strategic decisions, or operational changes that would significantly impact the company's stock or stakeholders.
The announcement is a routine intimation about the upcoming Annual General Meeting and related book closure dates, which is a standard corporate procedure and does not inherently carry positive or negative implications.
Aurobindo Pharma Limited has announced that its 39th Annual General Meeting (AGM) will be held on Thursday, August 27, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The Notice of the 39th AGM and the Integrated Annual Report for the financial year 2025-26 will be disseminated to shareholders. Those with registered email IDs will receive it directly, while others will receive a letter with instructions to access the documents online. The company's website, www.aurobindo.com, will also feature these documents in the investors section.
In accordance with Section 91 of the Companies Act, 2013, and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will be closed from Wednesday, August 26, 2026, to Thursday, August 27, 2026, inclusive, for the purpose of the AGM.
What to do with a filing like this
Aurobindo Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aurobindo Pharma Limited. Read the original for the full detail.